CHF Solutions News - CHFS

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
CHF Solutions Inc CHFS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.1315 38.85% 0.47 0.32 0.49 0.33 0.3385 19:59:42
more quote information »

Recent News

Date Time Source Heading
2/26/202008:00GLOBECHF Solutions receives 510(k) clearance for Aquadex..
2/25/202008:00GLOBECHF Solutions, Inc. To Announce Fourth Quarter and Year-End..
2/15/202001:01EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202017:59EDGARAmended Statement of Ownership (sc 13g/a)
2/12/202017:04EDGARAmended Statement of Ownership (sc 13g/a)
2/12/202009:15GLOBECHF Solutions Expands Commercial Presence in Europe with..
2/11/202016:45GLOBECHF Solutions, Inc. Reports Inducement Grants Under NASDAQ..
2/05/202013:57EDGARStatement of Ownership (sc 13g)
2/05/202008:00GLOBECHF Solutions Receives CE Mark for its New Aquadex..
2/03/202011:07EDGARStatement of Ownership (sc 13g)
1/30/202008:00GLOBECHF Solutions Expands its Patent Portfolio with Four..
1/29/202006:07EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
1/29/202006:06EDGARCurrent Report Filing (8-k)
1/28/202016:10GLOBECHF Solutions, Inc. Announces Closing of $9.66 Million..
1/27/202006:03EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
1/27/202006:01EDGARNotice of Effectiveness (effect)
1/24/202009:37GLOBECHF Solutions, Inc. Announces Pricing of $8.4 Million..
1/24/202009:35EDGARRegistration of Additional Securities (up to 20%) (s-1mef)
1/23/202017:04EDGARSecurities Registration Statement (s-1/a)
1/23/202009:31EDGARSecurities Registration Statement (s-1/a)
1/22/202008:00GLOBECHF Solutions Announces Launch of Aquapheresis Therapy Using..
1/08/202015:04EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
1/08/202008:00GLOBECHF Solutions Announces Presentation of Clinical Data with..
1/08/202006:03EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
1/06/202018:14EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
1/06/202006:02EDGARSecurities Registration Statement (s-1/a)
12/31/201906:01EDGARNotice of Effectiveness (effect)
12/27/201917:29EDGARSecurities Registration Statement (s-1/a)
12/20/201916:57EDGARSecurities Registration Statement (s-1)
12/20/201916:53EDGARSecurities Registration Statement (s-1/a)
12/20/201916:27EDGARCurrent Report Filing (8-k)
12/06/201917:22EDGARCurrent Report Filing (8-k)
12/06/201909:10EDGARSecurities Registration Statement (s-1)
12/03/201908:00GLOBECHF Solutions Announces Launch of Ultrafiltration Therapy..
11/27/201916:31EDGARAmended Statement of Ownership (sc 13g/a)
11/21/201917:19EDGARSmall Company Offering and Sale of Securities Without..
11/15/201917:30GLOBECHF Solutions, Inc. Reports Inducement Grants Under NASDAQ..
11/14/201916:18EDGARAmended Statement of Ownership (sc 13g/a)
11/08/201917:03EDGARQuarterly Report (10-q)
11/07/201916:40EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
11/05/201916:21EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/05/201908:16EDGARCurrent Report Filing (8-k)
11/05/201908:00GLOBECHF Solutions, Inc. Announces Third Quarter Financial..
11/04/201917:07EDGARCurrent Report Filing (8-k)
11/04/201909:19GLOBECHF Solutions, Inc. Announces Pricing of Registered Direct..
11/01/201916:13EDGARStatement of Ownership (sc 13g)
11/01/201915:27EDGARSmall Company Offering and Sale of Securities Without..
11/01/201908:00GLOBECHF Solutions, Inc. Announces Sales Force Realignment To..
10/29/201908:00GLOBECHF Solutions, Inc. To Announce Third Quarter 2019 Financial..
10/25/201916:33EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
See more news about this stock »

Your Recent History
CHF Soluti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.